We are international
• health professionals TEXT SIZE   
webcasts    back

Dr. Kaufman - ASH 2008 - First Trial of Humanized Anti-CD74 Monoclonal Antibody (MAb), Milatuzumab, in Multiple Myeloma
Jonathan Kaufman, MD
Emory University School of Medicine
Winship Cancer Institute
Atlanta Georgia

To view the video full screen, click on the small button next to the volume control in the lower right hand corner.

 related articles